HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Metastatic malignant melanoma — Clinical Guidelines

Overview

Metastatic malignant melanoma refers to the spread of melanoma beyond its primary cutaneous site, often involving vital organs such as the liver, brain, and lungs, with a notably poor prognosis despite advancements in treatment. 1 5

Diagnosis

Imaging studies (CT, MRI, PET) to identify metastatic sites.

Biopsy confirmation of metastatic lesions.

Multiplex Immunochemistry/Immunofluorescence (mIHC/IF) for detailed tumor microenvironment characterization 3.

Consider atypical presentations like cystic renal masses or mimicking subdural hematoma 9 11.

Management

First-line treatments:

- Immune checkpoint inhibitors (ICIs) such as tebentafusp for specific patient populations 1. - Vemurafenib for BRAF V600 mutation (though less common in uveal melanoma) 4.

Adjunctive therapies:

- Chemotherapy shows limited efficacy 1. - Liver-directed therapies for hepatic metastases are under investigation 5. - Neurosurgical interventions like MR-guided Laser Interstitial Thermal Therapy (MRgLITT) for intractable pain 2.

Special Populations

Elderly: Utilization patterns of end-of-life care (surgery, chemotherapy, radiation, hospice) vary significantly; hospice use correlates with improved survival and cost-effectiveness 7 8.

Comorbidities: Management strategies may need adjustment based on comorbid conditions, though specific guidelines are lacking in provided abstracts.

Key Recommendations

Utilize immune checkpoint inhibitors, particularly tebentafusp, for metastatic uveal melanoma patients, given limited targeted therapy options (Evidence: Moderate 1).

Consider MR-guided Laser Interstitial Thermal Therapy for patients with medically intractable pain due to metastatic melanoma (Evidence: Weak 2).

Evaluate hospice care early in the management of metastatic melanoma patients to potentially improve quality of life and survival (Evidence: Moderate 7 8).

References

1 Rodrigues M, Servois V, Mariani P, Pracht M, Dutriaux C, Grillet F et al.. Management of metastatic uveal melanoma: French expert consensus guidelines. Bulletin du cancer 2025. link 2 Aubignat M, Constans JM, Ouendo M, Arnault JP, Josse C, Desenclos C et al.. MR-guided Laser Interstitial Thermal Therapy mesencephalotomy for medically intractable malignant pain. Acta neurochirurgica 2025. link 3 Park SM, Chen CJ, Mathy JE, Lin SCY, Martin RCW, Mathy JA et al.. Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections. Journal of immunological methods 2023. link 4 Liu Y, Dong C, He X, Shu Y, Wu P, Zou J. Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2022. link 5 Comito F, Marchese PV, Ricci AD, Tober N, Peterle C, Sperandi F et al.. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives. Future oncology (London, England) 2021. link 6 Anforth RM, Carlos GR, Scolyer RA, Chou S, Fernandez-Peñas P. Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma. Melanoma research 2015. link 7 Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA et al.. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. American journal of clinical oncology 2015. link 8 Huo J, Lairson DR, Du XL, Chan W, Buchholz TA, Guadagnolo BA. Survival and cost-effectiveness of hospice care for metastatic melanoma patients. The American journal of managed care 2014. link 9 Tipton A, Goldman SM, Fishman EK, Arnold P. Cystic renal melanoma: CT/ultrasound correlation. Urologic radiology 1987. link 10 Spera JA, Pollack HM, Banner MP, Brennan RE, Wein AJ. Metastatic malignant melanoma mimicking renal cell carcinoma. The Journal of urology 1984. link50605-9) 11 Palmer FJ, Poulgrain AP. Metastatic melanoma simulating subdural hematoma. Case report. Journal of neurosurgery 1978. link 12 ZuWallack RL, Urman JD, Lahiri B. Metastatic melanoma. Another cause of a solitary pulmonary nodule with an air bronchogram. Radiology 1977. link 13 Clifford JR, Kirgis HD, Connolly ES. Metastatic melanoma of the brain presenting as subarachnoid hemorrhage. Southern medical journal 1975. link

Metastatic malignant melanoma